Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Overview
  • Distribution
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Overview
  • Distribution by PR Newswire
  • Guaranteed Paid Placement
  • SocialBoost
  • Multichannel Amplification
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Frost & Sullivan Commends CapsoVision's Ongoing Technology Advancement and Market Growth in the Capsule Endoscopy Market
  • USA - English

CapsoVision

News provided by

Frost & Sullivan

19 May, 2016, 17:30 IST

Share this article

Share toX

Share this article

Share toX

CapsoVision is set to achieve superior diagnostic accuracy and continues to lead through the development of next-generation product features and technologies.

MOUNTAIN VIEW, California, May 19, 2016 /PRNewswire/ -- Based on recent analysis of the gastrointestinal (GI) capsule endoscopy market, Frost & Sullivan recognizes CapsoVision, Inc. as the recipient of the 2016 European Enabling Technology Leadership award. CapsoVision's flagship technology platform, CapsoCam®, may well unlock wireless capsule endoscopy's (WCE) potential to become the new gold standard in GI endoscopy. CapsoCam®'s unique features help eliminate many of the bottlenecks in existing technologies and deliver fast, efficient, and higher diagnostic accuracy.

Logo - http://photos.prnewswire.com/prnh/20160518/369541LOGO

CapsoVision is paving the way for the next generation of GI capsule endoscopes. The CapsoCam® system consists of several well-integrated components such as the vitamin-sized endoscopic capsule camera, CapsoCam®; a capsule retrieval and storage kit, CapsoRetrieve®; a USB-connected data access system, CapsoAccess®; and computer software for image review, analysis and diagnostic reporting, CapsoView®.

While competing WCE technologies offer a limited view field because of a single wide-lens camera and a light source positioned at one end of the capsule, CapsoCam® presents a 360-degree panoramic view. CapsoCam® boasts an imaging system that employs 4 cameras located along the circumference, oriented towards the sides of the capsule. Each camera has an almost 90-degree field of view and captures high-resolution images at a rate of 5 frames per second (fps), for a total maximum frame rate of 20 fps, whereas most peer solutions offer frame rates of 2 fps to 6 fps.

"Another distinct feature of the CapsoCam® is its wire-free design, which enhances patient comfort and freedom, reduces procedure costs, and reduces potential safety issues associated with wireless data transmission," said Frost & Sullivan Best Practices Analyst, Norma Vela. "Its onboard flash memory reduces the need for additional equipment, giving patients and physicians more flexibility while simultaneously eliminating the inherent risks of implanted devices such as pacemakers and defibrillators."

With its Smart Motion Sense™ and Auto Illumination technologies, CapsoCam® lowers data redundancy, optimises lighting, and extends battery life. Using Smart Motion Sense™, the device records images whilst in motion and hibernates in stationary mode. The auto illumination regulator adjusts the LED intensity during the examination to provide the best light, aiding in clear and sharp visualization and power savings.

Following the success of CapsoCam® SV-1, CapsoVision launched the second generation of the system, CapsoCam® SV-2. This product delivered the same advantages of CapsoCam® SV-1 but with a more user-friendly data access system. By 2015, the company had also introduced its newly redesigned software, CapsoView® v3.0, which is more intuitive and easy-to-use and has a flexible user interface designed to decrease diagnostic reading time. Released in early 2016, the third generation CapsoCam® Plus aims for greater diagnostic utility by providing nearly double the resolution of previous models, allowing for greater clarity and more detailed imaging.

"By working closely with physicians, the company ensures that its development efforts and new product generation match the needs of the marketplace," noted Vela. "With each innovation, CapsoVision refines its product design and technologies, thus closing the gaps in yield and accuracy for diagnostic performance."

Because of its technological advances, innovative product design, and strong commitment to improving disease management in gastroenterology, CapsoVision is the deserving recipient of Frost & Sullivan's 2016 European Enabling Technology Leadership award in the GI capsule endoscopy market.

Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that enhances current products and stokes the development of newer products and applications. The award recognises the high market acceptance potential of the recipient's technology.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

As a Growth Partnership company, Frost & Sullivan collaborates with clients to leverage visionary innovation to address global challenges and related growth opportunities that could make or break today's market participants.

Frost & Sullivan's Growth Partnership supports clients by addressing these opportunities and incorporating 2 key elements driving visionary innovation: the Integrated Value Proposition and the Partnership Infrastructure.

  • The Integrated Value Proposition provides support to clients throughout all phases of their journey to visionary innovation, including research, analysis, strategy, vision, innovation, and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible, including 360 degree research, comprehensive industry coverage, and career best practices as well as Frost & Sullivan's global footprint of more than 40 offices.

For more than 50 years, Frost & Sullivan has been developing growth strategies for the global 1,000; emerging businesses; the public sector; and the investment community.

Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics, and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Contact:

Chiara Carella
P: +44 (0) 207.343.8314
F: +1 210.348.1003
E: [email protected]

Related Links

http://www.frost.com

Modal title

Also from this source

Index Exchange Receives Frost & Sullivan's 2025 Global New Product Innovation Recognition for Leadership in Supply-Side Platforms

Frost & Sullivan is pleased to announce that Index Exchange Inc (Index), one of the world's largest independent supply-side platforms (SSPs), has...

BioCatch Receives Frost & Sullivan's 2025 Global Competitive Strategy Leadership Recognition for Excellence in Fraud Detection and Prevention

Frost & Sullivan is pleased to announce that BioCatch, which prevents financial crime by recognizing patterns in human behavior, has earned the 2025...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.